Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameSunshine Pharma
Stock Code06887
Company Full NameSunshine Lake Pharma Co., Ltd.
IndustryHealthcare
Principal ActivitiesA comprehensive pharmaceutical company engaged in the research and development, production and commercialization of drugs, focusing on therapeutic areas such as infectious diseases, chronic diseases and oncology.
Listing Date2025-08-07
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國廣東省東莞市松山湖園區工業北路1號
Business Address (Hong Kong)香港灣仔皇后大道東248號大新金融中心40樓
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehecpharm.com
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact卓佳证券登记有限公司,香港金钟道89号力宝中心1座31楼3101-3103室
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceTo be extracted
Offer Price RangeTo be extracted
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueRMB 1.0 / shares
Offer PeriodTo be extracted
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPO576,656,047 shares
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone ShareNo cornerstone investors
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeTo be extracted

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
HK Market Cap HK$ 12.54B
Est. Threshold HK$ 9.37B
Analysis Result HK market cap met, expected inclusion ~2027-03-08

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot applicable (loss-making)
Profit/Loss StatusNet profit RMB 24.8 million
Period-End Cash BalanceRMB 1,480.81 million
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day CloseLoading...

Underwriting Syndicate

Sponsor
中國國際金融香港證券有限公司
Reporting Accountant
畢馬威會計師事務所
Property Valuer
不適用

Cornerstone Investors

No data

Directors & Management

PositionChinese nameEnglish Name
Chairman張英俊—
Company Secretary鄭程傑—
No director data available.

Major Shareholders

Major Shareholders & HoldingsThe controlling shareholders are a group of shareholders including Mr. Zhang, Ms. Guo, Guangdong Dongyangguang Technology and others, who directly or indirectly control 50.98% of the voting rights of the Company immediately after the Listing.
About this page

This page shows Sunshine Pharma (06887) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect